CN Stock MarketDetailed Quotes

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Watchlist

7.86
-0.08-1.01%

Not Open Oct 15 15:00 CST

957.18MMarket Cap-28686P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

Assets

Current assets

Money funds

945.20%71.31M

106.29%55.92M

131.08%97.96M

384.85%100.95M

-25.54%6.82M

100.42%27.11M

90.18%42.39M

-49.26%20.82M

-72.94%9.16M

333.68%13.53M

Notes receivable and accounts receivable

2.38%31.47M

29.82%39.94M

19.08%36.68M

-27.99%29.51M

-31.12%30.74M

-37.98%30.77M

-40.09%30.81M

-13.15%40.99M

-15.99%44.63M

-4.29%49.61M

-Accounts receivable

2.38%31.47M

29.82%39.94M

19.08%36.68M

-27.99%29.51M

-31.12%30.74M

-37.98%30.77M

-40.09%30.81M

-13.15%40.99M

-15.99%44.63M

-4.29%49.61M

Other receivables (including interest and dividends)

-13.59%2.35M

18.53%2.13M

12.05%2M

-92.43%1.74M

-94.90%2.72M

-96.89%1.8M

-96.74%1.79M

-55.67%22.99M

-22.65%53.35M

-41.54%57.76M

-Other receivable

-13.59%2.35M

----

12.05%2M

----

-94.90%2.72M

----

-96.74%1.79M

----

-22.65%53.35M

----

Advance payment

28.78%6.43M

311.11%5.94M

7.89%1.1M

140.19%5.42M

45.90%4.99M

-68.38%1.44M

-68.21%1.02M

-38.37%2.26M

12.84%3.42M

-20.26%4.57M

Inventories

13.11%53.22M

-7.84%45.36M

-9.70%42.95M

-26.97%41.85M

-13.31%47.05M

-6.04%49.22M

-9.16%47.56M

1.69%57.3M

1.14%54.27M

-16.51%52.38M

Receivable financing

--1.35M

-67.37%400.7K

50.53%277.4K

--1.28M

----

--1.23M

-54.52%184.29K

----

Other current assets

135.76%1.33M

-22.32%688.21K

37.77%524.89K

-44.71%302.41K

30.16%564.35K

20.82%885.97K

-74.08%381.01K

-45.65%546.94K

-37.95%433.59K

-23.12%733.31K

Total current assets

80.28%167.46M

33.73%150.38M

46.21%181.5M

24.96%181.06M

-43.80%92.89M

-37.03%112.45M

-33.29%124.13M

-28.61%144.9M

-23.21%165.27M

-20.77%178.58M

Non Current assets

Fixed assets

-5.27%134.82M

----

-9.38%139.78M

----

-20.52%142.32M

----

-16.74%154.24M

----

32.42%179.07M

----

Constru in process

1,225.97%5.53M

----

-84.19%17.4K

----

-95.16%416.86K

----

-98.72%110.03K

----

-86.17%8.62M

----

Intangible assets

-2.40%5.17M

-2.90%5.18M

-2.88%5.21M

-2.86%5.25M

-2.84%5.29M

-2.82%5.33M

-2.80%5.37M

-2.78%5.41M

-2.76%5.45M

-2.74%5.49M

Goodwill

0.00%2.2M

----

0.00%2.2M

-19.28%2.2M

-33.67%2.2M

-51.74%2.72M

-41.26%3.31M

Long deferred expense

63.27%3.14M

1.26%2.2M

-11.24%2.2M

-65.66%1.45M

-60.62%1.92M

-58.61%2.17M

-58.26%2.48M

-29.00%4.23M

-17.01%4.89M

-19.36%5.25M

Deferred tax assets

371.08%3.41M

152.88%1.83M

1.86%3.51M

-63.49%724.28K

73.88%3.45M

58.09%1.98M

Usufruct assets

5.40%11.42M

26.17%12.31M

12.11%11.87M

92.45%9.99M

99.21%10.84M

71.36%9.75M

78.08%10.58M

--5.19M

--5.44M

--5.69M

Other non current assets

----

--3.51M

----

Total non current assets

1.20%165.69M

-5.51%162.3M

-7.65%164.79M

-21.89%159.38M

-21.35%163.72M

-19.12%171.76M

-17.61%178.43M

-5.50%204.04M

-3.59%208.16M

-1.41%212.36M

Total assets

29.83%333.15M

10.02%312.68M

14.45%346.29M

-2.43%340.44M

-31.29%256.61M

-27.30%284.21M

-24.86%302.57M

-16.70%348.94M

-13.38%373.44M

-11.31%390.95M

Liabilities

Current liabilities

Short term loan

-30.61%72.57M

-30.67%72.45M

-1.91%102.64M

-1.91%102.5M

-0.04%104.58M

-1.42%104.5M

-1.97%104.64M

-1.98%104.5M

2.49%104.62M

-6.01%106.01M

Notes payable and accounts payable

80.94%69.87M

39.22%65.05M

8.46%51.22M

-27.35%39.71M

-35.26%38.61M

-29.91%46.72M

-28.48%47.22M

-29.07%54.65M

-20.90%59.65M

-11.09%66.66M

-Notes payable

--19.03M

--6.55M

----

-Accounts payable

31.65%50.84M

25.20%58.5M

8.46%51.22M

-27.35%39.71M

-35.26%38.61M

-29.91%46.72M

-28.48%47.22M

-29.07%54.65M

-20.90%59.65M

-11.09%66.66M

Contract liabilities

-6.46%2.76M

-3.76%3.81M

-5.40%3.39M

-42.75%3.34M

-55.01%2.96M

36.49%3.96M

19.68%3.58M

104.85%5.84M

128.56%6.57M

-7.00%2.9M

Salaries payable

-21.94%4.48M

-6.09%6.24M

-16.89%6.78M

-33.32%5.29M

-40.23%5.73M

11.90%6.64M

26.33%8.15M

12.79%7.93M

48.00%9.59M

-1.53%5.94M

Taxs payable

-20.58%1.42M

170.65%3.84M

94.12%4.72M

5.88%2.15M

-15.61%1.79M

-43.51%1.42M

-40.26%2.43M

12.66%2.03M

-12.24%2.12M

-20.66%2.51M

Other payable (including interest and dividends)

50.28%70.77M

-12.91%42.99M

-8.91%46.27M

114.56%135.76M

-29.57%47.09M

-23.15%49.36M

-19.40%50.8M

10.40%63.27M

6.01%66.86M

17.40%64.23M

-Dividend payable

0.00%23.4K

-Other payable

50.30%70.75M

----

-8.91%46.25M

----

-29.58%47.07M

----

-19.40%50.78M

----

6.02%66.84M

----

Non current liabilities due within one year

13.80%4.1M

9.85%3.95M

25.58%4.9M

284.32%3.6M

209.87%3.6M

166.73%3.9M

103.56%936.58K

152.46%1.16M

Other current liabilities

-6.53%358.63K

11.59%489.48K

-5.15%464.42K

-42.16%433.2K

-55.05%383.68K

21.50%438.65K

31.10%489.64K

102.33%749.02K

128.65%853.61K

-34.41%361.04K

Total current liabilities

10.54%226.32M

-8.23%198.81M

-0.38%220.38M

22.04%292.77M

-18.49%204.75M

-13.26%216.64M

-11.92%221.22M

-5.36%239.9M

-0.77%251.2M

-2.36%249.76M

Current liabilities

Estimate liabilities

-94.17%83.33K

-19.77%1.15M

-58.89%1.43M

-61.16%1.43M

155.46%3.48M

170.35%3.68M

Deferred tax liabilities

--2.86M

--2.97M

12.11%2.97M

----

--2.65M

----

Long term deferred income

-10.32%56.45M

-10.18%57.52M

-10.16%58.62M

-11.23%61.95M

-13.40%62.95M

-15.00%64.04M

-17.10%65.25M

-15.63%69.78M

-15.47%72.69M

-15.60%75.34M

Lease liabilities

-5.20%6.3M

-15.88%6.39M

-3.10%7.23M

39.97%6.66M

33.89%6.64M

63.51%7.59M

63.98%7.46M

--4.76M

--4.96M

--4.64M

Total non current liabilities

-7.51%65.69M

-6.90%68.02M

-8.89%69.96M

-10.23%70.03M

-12.46%71.02M

-12.67%73.06M

-11.68%76.79M

-11.82%78.02M

-11.57%81.13M

-11.96%83.66M

Total liabilities

5.89%292.01M

-7.90%266.83M

-2.57%290.34M

14.12%362.8M

-17.02%275.77M

-13.11%289.7M

-11.86%298.01M

-7.03%317.92M

-3.65%332.33M

-4.96%333.42M

Shareholders equity

Paid-in capital

0.00%121.78M

Capital reserve funds

123.65%162.79M

10.79%72.79M

11.91%72.79M

4.45%65.7M

3.41%65.04M

Surplus reserve funds

0.00%24.18M

Retained profit

-12.97%-290.11M

-16.05%-281.33M

-16.40%-271.61M

-33.04%-260.83M

-37.27%-256.8M

-41.24%-242.43M

-40.72%-233.34M

-29.72%-196.06M

-31.59%-187.07M

-23.41%-171.64M

Shareholders equity without minority interests

148.98%18.64M

215.76%27.42M

354.60%37.14M

-369.83%-42.09M

-254.74%-38.05M

-160.17%-23.68M

-132.28%-14.59M

-72.98%15.6M

-63.13%24.59M

-43.59%39.36M

Minority interests

19.13%22.5M

1.36%18.43M

-1.75%18.81M

27.88%19.72M

14.34%18.88M

0.11%18.19M

-1.18%19.15M

-19.74%15.42M

-15.48%16.52M

-10.08%18.17M

Total shareholder equity

314.65%41.13M

934.52%45.85M

1,127.18%55.95M

-172.08%-22.36M

-146.62%-19.16M

-109.55%-5.49M

-92.94%4.56M

-59.68%31.02M

-52.33%41.11M

-36.07%57.53M

Total liabilityies and equity

29.83%333.15M

10.02%312.68M

14.45%346.29M

-2.43%340.44M

-31.29%256.61M

-27.30%284.21M

-24.86%302.57M

-16.70%348.94M

-13.38%373.44M

-11.31%390.95M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion with explanatory notes

Auditor

Unitai Zhenqing Certified Public Accountants (Special General Partnership)

ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022
Assets
Current assets
Money funds	945.20%71.31M	106.29%55.92M	131.08%97.96M	384.85%100.95M	-25.54%6.82M	100.42%27.11M	90.18%42.39M	-49.26%20.82M	-72.94%9.16M	333.68%13.53M
Notes receivable and accounts receivable	2.38%31.47M	29.82%39.94M	19.08%36.68M	-27.99%29.51M	-31.12%30.74M	-37.98%30.77M	-40.09%30.81M	-13.15%40.99M	-15.99%44.63M	-4.29%49.61M
-Accounts receivable	2.38%31.47M	29.82%39.94M	19.08%36.68M	-27.99%29.51M	-31.12%30.74M	-37.98%30.77M	-40.09%30.81M	-13.15%40.99M	-15.99%44.63M	-4.29%49.61M
Other receivables (including interest and dividends)	-13.59%2.35M	18.53%2.13M	12.05%2M	-92.43%1.74M	-94.90%2.72M	-96.89%1.8M	-96.74%1.79M	-55.67%22.99M	-22.65%53.35M	-41.54%57.76M
-Other receivable	-13.59%2.35M	----	12.05%2M	----	-94.90%2.72M	----	-96.74%1.79M	----	-22.65%53.35M	----
Advance payment	28.78%6.43M	311.11%5.94M	7.89%1.1M	140.19%5.42M	45.90%4.99M	-68.38%1.44M	-68.21%1.02M	-38.37%2.26M	12.84%3.42M	-20.26%4.57M
Inventories	13.11%53.22M	-7.84%45.36M	-9.70%42.95M	-26.97%41.85M	-13.31%47.05M	-6.04%49.22M	-9.16%47.56M	1.69%57.3M	1.14%54.27M	-16.51%52.38M
Receivable financing	--1.35M	-67.37%400.7K	50.53%277.4K	--1.28M	----	--1.23M	-54.52%184.29K	----	----	----
Other current assets	135.76%1.33M	-22.32%688.21K	37.77%524.89K	-44.71%302.41K	30.16%564.35K	20.82%885.97K	-74.08%381.01K	-45.65%546.94K	-37.95%433.59K	-23.12%733.31K
Total current assets	80.28%167.46M	33.73%150.38M	46.21%181.5M	24.96%181.06M	-43.80%92.89M	-37.03%112.45M	-33.29%124.13M	-28.61%144.9M	-23.21%165.27M	-20.77%178.58M
Non Current assets
Fixed assets	-5.27%134.82M	----	-9.38%139.78M	----	-20.52%142.32M	----	-16.74%154.24M	----	32.42%179.07M	----
Constru in process	1,225.97%5.53M	----	-84.19%17.4K	----	-95.16%416.86K	----	-98.72%110.03K	----	-86.17%8.62M	----
Intangible assets	-2.40%5.17M	-2.90%5.18M	-2.88%5.21M	-2.86%5.25M	-2.84%5.29M	-2.82%5.33M	-2.80%5.37M	-2.78%5.41M	-2.76%5.45M	-2.74%5.49M
Goodwill	0.00%2.2M	----	0.00%2.2M	-19.28%2.2M	-19.28%2.2M	-33.67%2.2M	-33.67%2.2M	-51.74%2.72M	-51.74%2.72M	-41.26%3.31M
Long deferred expense	63.27%3.14M	1.26%2.2M	-11.24%2.2M	-65.66%1.45M	-60.62%1.92M	-58.61%2.17M	-58.26%2.48M	-29.00%4.23M	-17.01%4.89M	-19.36%5.25M
Deferred tax assets	371.08%3.41M	152.88%1.83M	1.86%3.51M	-63.49%724.28K	-63.49%724.28K	-63.49%724.28K	73.88%3.45M	58.09%1.98M	58.09%1.98M	58.09%1.98M
Usufruct assets	5.40%11.42M	26.17%12.31M	12.11%11.87M	92.45%9.99M	99.21%10.84M	71.36%9.75M	78.08%10.58M	--5.19M	--5.44M	--5.69M
Other non current assets	----	--3.51M	----	----	----	----	----	----	----	----
Total non current assets	1.20%165.69M	-5.51%162.3M	-7.65%164.79M	-21.89%159.38M	-21.35%163.72M	-19.12%171.76M	-17.61%178.43M	-5.50%204.04M	-3.59%208.16M	-1.41%212.36M
Total assets	29.83%333.15M	10.02%312.68M	14.45%346.29M	-2.43%340.44M	-31.29%256.61M	-27.30%284.21M	-24.86%302.57M	-16.70%348.94M	-13.38%373.44M	-11.31%390.95M
Liabilities
Current liabilities
Short term loan	-30.61%72.57M	-30.67%72.45M	-1.91%102.64M	-1.91%102.5M	-0.04%104.58M	-1.42%104.5M	-1.97%104.64M	-1.98%104.5M	2.49%104.62M	-6.01%106.01M
Notes payable and accounts payable	80.94%69.87M	39.22%65.05M	8.46%51.22M	-27.35%39.71M	-35.26%38.61M	-29.91%46.72M	-28.48%47.22M	-29.07%54.65M	-20.90%59.65M	-11.09%66.66M
-Notes payable	--19.03M	--6.55M	----	----	----	----	----	----	----	----
-Accounts payable	31.65%50.84M	25.20%58.5M	8.46%51.22M	-27.35%39.71M	-35.26%38.61M	-29.91%46.72M	-28.48%47.22M	-29.07%54.65M	-20.90%59.65M	-11.09%66.66M
Contract liabilities	-6.46%2.76M	-3.76%3.81M	-5.40%3.39M	-42.75%3.34M	-55.01%2.96M	36.49%3.96M	19.68%3.58M	104.85%5.84M	128.56%6.57M	-7.00%2.9M
Salaries payable	-21.94%4.48M	-6.09%6.24M	-16.89%6.78M	-33.32%5.29M	-40.23%5.73M	11.90%6.64M	26.33%8.15M	12.79%7.93M	48.00%9.59M	-1.53%5.94M
Taxs payable	-20.58%1.42M	170.65%3.84M	94.12%4.72M	5.88%2.15M	-15.61%1.79M	-43.51%1.42M	-40.26%2.43M	12.66%2.03M	-12.24%2.12M	-20.66%2.51M
Other payable (including interest and dividends)	50.28%70.77M	-12.91%42.99M	-8.91%46.27M	114.56%135.76M	-29.57%47.09M	-23.15%49.36M	-19.40%50.8M	10.40%63.27M	6.01%66.86M	17.40%64.23M
-Dividend payable	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K	0.00%23.4K
-Other payable	50.30%70.75M	----	-8.91%46.25M	----	-29.58%47.07M	----	-19.40%50.78M	----	6.02%66.84M	----
Non current liabilities due within one year	13.80%4.1M	9.85%3.95M	25.58%4.9M	284.32%3.6M	284.32%3.6M	209.87%3.6M	166.73%3.9M	103.56%936.58K	103.56%936.58K	152.46%1.16M
Other current liabilities	-6.53%358.63K	11.59%489.48K	-5.15%464.42K	-42.16%433.2K	-55.05%383.68K	21.50%438.65K	31.10%489.64K	102.33%749.02K	128.65%853.61K	-34.41%361.04K
Total current liabilities	10.54%226.32M	-8.23%198.81M	-0.38%220.38M	22.04%292.77M	-18.49%204.75M	-13.26%216.64M	-11.92%221.22M	-5.36%239.9M	-0.77%251.2M	-2.36%249.76M
Current liabilities
Estimate liabilities	-94.17%83.33K	-19.77%1.15M	-19.77%1.15M	-58.89%1.43M	-58.89%1.43M	-61.16%1.43M	-61.16%1.43M	155.46%3.48M	155.46%3.48M	170.35%3.68M
Deferred tax liabilities	--2.86M	--2.97M	12.11%2.97M	----	----	----	--2.65M	----	----	----
Long term deferred income	-10.32%56.45M	-10.18%57.52M	-10.16%58.62M	-11.23%61.95M	-13.40%62.95M	-15.00%64.04M	-17.10%65.25M	-15.63%69.78M	-15.47%72.69M	-15.60%75.34M
Lease liabilities	-5.20%6.3M	-15.88%6.39M	-3.10%7.23M	39.97%6.66M	33.89%6.64M	63.51%7.59M	63.98%7.46M	--4.76M	--4.96M	--4.64M
Total non current liabilities	-7.51%65.69M	-6.90%68.02M	-8.89%69.96M	-10.23%70.03M	-12.46%71.02M	-12.67%73.06M	-11.68%76.79M	-11.82%78.02M	-11.57%81.13M	-11.96%83.66M
Total liabilities	5.89%292.01M	-7.90%266.83M	-2.57%290.34M	14.12%362.8M	-17.02%275.77M	-13.11%289.7M	-11.86%298.01M	-7.03%317.92M	-3.65%332.33M	-4.96%333.42M
Shareholders equity
Paid-in capital	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M	0.00%121.78M
Capital reserve funds	123.65%162.79M	123.65%162.79M	123.65%162.79M	10.79%72.79M	10.79%72.79M	11.91%72.79M	11.91%72.79M	4.45%65.7M	4.45%65.7M	3.41%65.04M
Surplus reserve funds	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M	0.00%24.18M
Retained profit	-12.97%-290.11M	-16.05%-281.33M	-16.40%-271.61M	-33.04%-260.83M	-37.27%-256.8M	-41.24%-242.43M	-40.72%-233.34M	-29.72%-196.06M	-31.59%-187.07M	-23.41%-171.64M
Shareholders equity without minority interests	148.98%18.64M	215.76%27.42M	354.60%37.14M	-369.83%-42.09M	-254.74%-38.05M	-160.17%-23.68M	-132.28%-14.59M	-72.98%15.6M	-63.13%24.59M	-43.59%39.36M
Minority interests	19.13%22.5M	1.36%18.43M	-1.75%18.81M	27.88%19.72M	14.34%18.88M	0.11%18.19M	-1.18%19.15M	-19.74%15.42M	-15.48%16.52M	-10.08%18.17M
Total shareholder equity	314.65%41.13M	934.52%45.85M	1,127.18%55.95M	-172.08%-22.36M	-146.62%-19.16M	-109.55%-5.49M	-92.94%4.56M	-59.68%31.02M	-52.33%41.11M	-36.07%57.53M
Total liabilityies and equity	29.83%333.15M	10.02%312.68M	14.45%346.29M	-2.43%340.44M	-31.29%256.61M	-27.30%284.21M	-24.86%302.57M	-16.70%348.94M	-13.38%373.44M	-11.31%390.95M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion with explanatory notes	--	--	--	Unqualified opinion with explanatory notes	--	--	--
Auditor	--	--	Unitai Zhenqing Certified Public Accountants (Special General Partnership)	--	--	--	ZTE Finance Guanghua Certified Public Accountants (Special General Partnership)	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target